Radiolabelled peptides have attracted a great deal of attention due to their wide applicability in the development of target-specific radiopharmaceuticals. They can easily be used in diagnostic imaging as carriers for the delivery of radionuclides to tumors as well as for therapy. Previous investigations revealed that technetium(V) could form stable complexes with peptide-based ligands of N 3 S type such as Cys-Gly-Gly-Gly. Herein, a targeting HER-2 receptor peptide was labeled with technetium-99m ( 99m Tc) with two different types of tetrapeptide-based ligands, Cys-Gly-Gly-Gly and Cys-Ser-Ser-Ser. The effect of experimental parameters in the labeling procedure such as type of buffer solutions, pH of media, and type of exchange ligands were optimized toward obtaining maximum labeling yield. The optimum labeling conditions were different for two peptides. Shelf life of both labeled peptides was determined by analytical reversed-phase high-performance liquid chromatography (RP-HPLC) and thin layer chromatography (TLC) that showed radiochemical yield up to 95% even after 4 h.
Introduction
Recent years have witnessed an increasing interest in radiolabelled peptides for nuclear medicine applications. This emergence is attributed to the overexpression of many receptors in numerous cancers compared to their relatively low density in normal organs. 1 One of the most widely used diagnostic radionuclides is technetium-99m ( 99m Tc) due to short half-life and optimum energy gamma emission. On the other hand, the existence of technetium in many oxidation states from, −1 to +7, offers an advantage for doing the necessary chemistry to prepare the various radiopharmaceuticals. 2 Among these oxidation states, Tc 5+ is widely used in radiopharmaceutical formulations because of the stability of the resulting complexes TcO 3+ oxotechnecium(V) with quadridentate ligands such as N 3 S and N 2 S 2 . 3, 4 These complexes have a distorted square pyramidal structure with the oxo group perpendicular to the plane of the peptide nitrogen and sulfur coordinating atoms. It is noteworthy to mention that the presence of large S-donor atoms helps occupying the space around the metal ion more effectively compared to smaller N or O donor atoms. 5, 6 One of the design strategies for 99m Tc-labeled radiopharmaceuticals is bifunctional chelating agent (BFCA) approach in which BFCA is used for 99m Tc chelating. 7 An important property of BFCAs is the ability to form complexes with high in vivo stability. The attachment of the BFCA-radiometal complex to peptide occurs through the following reactive groups: N-hydroxysuccinimide (NHS) esters, isothiocyanates or maleimide moieties. 8 A wide variety of BFCAs and prosthetic groups such as mercaptoacetyltri-glycine (MAG3), diaminedithiol (DADT), 2-hydrazinonicotinic acid (HYNIC) and peptide based BFCA have been developed in recent years, allowing rapid and convenient radiolabeling of peptides with 99m Tc. 9 Among these various approaches, peptide labeling can be performed through peptide-based ligands via one-pot procedure and there is no need for a separate BFCA connection step. In other words, chelators consisting of amino acids may be added to small peptides during their solid phase synthesis. Targeting peptide containing tripeptide sequence Cys-Gly-Gly as N 3 S and Cys-Gly-Cys as N 2 S 2 groups can be chelated with 99m Tc. 10 These tripeptide chelating sequences usually form stable technetium complexes with the [TcO] 3+ core. Coordination of the radiometal to a linear peptide increases the receptor binding affinity to its intended receptor by creating a constrained macrocyclic metallopeptide with less conformational freedom. 11, 12 The site-specific metal cyclization can also improve the in vivo stability of the Vol. 27, No. 11, 2016 radiolabeled peptide. 13, 14 Moreover, peptide-based ligands can simplify the chemistry of adding the metal binding sites.
The aim of this study was to use the peptide sequences of cysteine-triserine (CSSS) and cysteine-triglycine (CGGG) that would enable labeling of LTVSPWY peptide with 99m Tc (Figure 1 ). Shadidi and Sioud 15 have identified a 7-mer peptide, referred to as LTVSPWY that exhibited preferential binding and internalization into breast cancer cell lines by HER-2 receptors.
Experimental

Materials and instruments
CGGGLTVSPWY and CSSSLTVSPWY peptides were synthesized and purchased from ProteoGenix (Schiltigheim, France). The 99m TcO 4 Na was eluted from a 99 Mo/ 99m Tc radionuclide generator (Parsisotope, Tehran, Iran). Acetonitrile (HPLC grade), sodium tartrate, sodium bicarbonate, phosphate, ammonium acetate, and ethylenediaminetetraacetic acid (EDTA) were obtained from Merck company (Darmstadt, Germany); trifluoroacetic acid (TFA), tin(II)-chloride dehydrate, gluconic acid sodium salt and tricine were from Sigma-Aldrich company (St. Louis, MO, USA). Solutions were prepared by standard procedures and using high-quality water. The distribution of radioactivity on the instant thin layer chromatography (ITLC) strips was quantified using a Lablogic mini scan TLC scanner (Sheffield, UK) and analyzed with Lura image analysis software. Radioactivity in the samples was measured using a gamma counter with a NaI (Tl) detector gamma detector (Delshid, Tehran, Iran). Analytical reversed-phase high-performance liquid chromatography (RP-HPLC) was performed on a Knauer HPLC system (Berlin, Germany). The HPLC analyses of radiolabelled peptides were performed on Lablogic radioactivity gamma detector (Sheffield, UK). Column: Eurospher 100-5 C18, 4.6 × 250 mm (Knauer, Berlin, Germany) with pre-column; the mobile phase consisted of (A) 0.1% TFA in acetonitrile and (B) H 2 O. RP-HPLC elution was performed with a solvent system consisting of: 0.1% TFA in acetonitrile ; all solvents were filtered and degassed earlier entering the column.
Radiolabeling methods for two peptides
Two different approaches were used for radiolabeling of these peptides. O gluconate precursor. For this purpose, 5 mg of sodium gluconate (C 6 H 11 NaO 7 ) and 10 mg of sodium bicarbonate (NaHCO 3 ) were dissolved in 100 µL of deionized water separately. To this mixture, 40 µL SnCl 2 (2 mg mL −1 , dissolved in 0.1 mol L −1 HCl) was added and followed by a sodium pertechnetate (Na For CSSSLTVSPWY, the optimum labeling reaction conditions was the same as CGGGLTVSPWY except for the amount of sodium bicarbonate, which was 25 mg and the activity of sodium pertechnetate was 100-200 MBq. Also, the peptide was dissolved in 100 µL ammonium acetate and the final volume of the mixture did not reach 1 mL.
Results
In direct labeling method, buffer solutions including PBS (pH 7.4), NH 4 OAc (pH 5.5) and NaOH (pH 12) were used. The amounts of SnCl 2 used were 20 to 40 µg. The reactions were accomplished at 90 o C and r.t. for 30 and 60 min. The obtained radiochemical yield in NH 4 OAc buffer was better than other buffers. In order to confirm the good shelf life (efficacy of labeled compounds in over a period of time) of radiolabeled complexes with no considerable release of 99m TcO 4 − , we checked shelf life up to 2 h by incubation of reaction mixture at r.t. However, the shelf life after 2 h was unacceptable; radiochemical yield was less than 86% (Supplementary Information, Table S1 ).
As a result, we switched to ligand exchange method in which different ligands were used such as sodium gluconate, tartrate, tricine, and MDP. In the case of gluconate ligand, different amounts of SnCl 2 (40 to 150 µg) was added to constant quantity of gluconate (5 mg) and was dissolved in PBS, ammonium acetate and normal saline ( 16 we decided to change the buffer solutions from PBS to alkaline buffers such as phosphonates or bicarbonate. All of the reactions were performed in one step, which means that the conditions of labeling for gluconate and peptide with 99m Tc were the same ( In the next strategy, sodium gluconate was dissolved it in bicarbonate buffer was used as ligand exchange. Labeling of gluconate in the presence of SnCl 2 with 99m Tc was performed in 10 min. After performing various set of reactions, we figured out that to obtain an effective radiolabeling it is essential to change the pH of the peptide media and to create acidic conditions (pH = 1-2). Hence, the combination of two mixtures results the pH of the final solution to be around 6-7, which prevented relabeling of gluconate with 99m Tc in the presence of peptide ( Table 2 , No. 29-32). Figure S1a ) and no reduced hydrolyzed technetium colloids (RHT; Supplementary Information, Figure S1b ). This result indicates the radiochemical yield of 100%.
After 1, 2 and 4 h, radiochemical yield were assessed by ITLC to be 97, 96 and 95%, respectively ( Supplementary  Information, Figure S2 ). In these conditions, RHT was not observed. Moreover, the yield was also assayed by RP-HPLC at 1 and 4 h. The retention time of peptide was from 18 to 20 min and for mixture of 99m TCO 4 − and 99m Tc-gluconate complexes was 2-4 min. The obtained radiochemical yield at 1 and 4 h was 97 and 95%, respectively (Figure 2 ). Resulting acceptable radiochemical yield due to single peak at 18-20 min retention time, showed a high specific activity (2-3 mCi per 10 µg or 8.42-12.64 GBq per µmol). S a m e o p t i m i z e d l a b e l i n g c o n d i t i o n s f o r CGGGLTVSPWY were repeated for CSSSLTVSPWY but the radiochemical yield was unsatisfactory. In order to optimize the labeling condition, dominant experimental parameters such as the quantity of SnCl 2 and the applied temperatures were changed as shown in Table 3 . However, an effective conjugation was not achieved (Table 3 , No. 1-3). Since CSSS amino acids sequence is structurally different from CGGGLTVSPWY due to the presence of serine groups in its structure, we decided to eliminate acidic media of peptide (pH = 1-2) due to prevent from protonating OH groups to obtain better radiolabeling. For this purpose, this peptide was dissolved in ammonium acetate and acetonitrile (Table 3 , No. 4-7). Also, ligand exchange was changed from gluconate to tartrate, and buffer was phosphate and phosphate-citrate (Table 3 , No. 8-41). But unfortunately, it was unsuccessful for obtaining a long-term stability for radiolabeled peptide Finally, for optimizing labeling condition, gluconate was used as ligand exchange while the amount of bicarbonate buffer was increased up to two times with the peptide dissolved in ammonium acetate (Table 3 , No. 42-43).
The radiochemical yield was checked by ITLC and RP-HPLC like CGGG-peptide. Radiochemical yield was 99% at 30 min and 1 h, while it was reduced to 98 and 97% at 2 and 4 h after reaction, respectively. To prove the stable shelf life, results of RP-HPLC was also reported at 1 and 4 h. Radiochemical yield were 97 and 95% at 1 and 4 h, respectively (Figure 3) . Resulting acceptable radiochemical yield due to single peak at 18-20 min retention time showed a high specific activity (3-4 mCi per 10 µg or 13.62-18.18 GBq per µmol).
Discussion
Biologically, active small peptides are favorable tools for diagnosis of various diseases because they offer many distinct advantages over proteins and monoclonal antibodies. Recently, a number of ( 99m Tc)-labeled bioactive peptides have discovered to be useful diagnostic imaging agents. N 3 S type ligand systems, such as Gly-Gly-Gly-Cys, form stable complexes with 185/187 Re (V) / 99m Tc (V) due to labeling peptide 18 in high yield and specific activity through the gluconate precursors. 4, 19 In the recent years, a series of studies involving labeling of affibody molecules with 99m Tc using peptide-based N 3 S chelators has been reported. Substitution of the amino acids forming the chelator for binding 99m Tc effected on the biodistribution of affibody molecules. [20] [21] [22] [23] [24] Our efforts were focused on radiolabeling of LTVSPWY peptide with 99m Tc by two cycteine-based ligands of Cys-Gly-Gly-Gly and Cys-Ser-Ser-Ser. 99m Tc radiolabeling of two peptides were accomplished through direct reduction and ligand exchange methods. In direct method, the use of reducing agents such as Sn (P) can produce 99m Tc intermediates that form unstable complexes with peptides. 25 In ligand exchange method, 99m Tc-chelate intermediate allowed to react to peptides under mild conditions to form final acceptable radiolabeled peptides. 26 For optimizing labeling, in direct method, the influence of pH (changing buffers from acidic to alkaline), concentration of SnCl 2 and temperature was investigated on radiochemical yield. Although, in acidic conditions (using buffer NH 4 OAc), maximum radiochemical yield was accepted but it was not stable for 2 h after labeling.
In indirect method, the effect of types of ligand exchanges (gluconate, tartarate, tricine and MDP) , buffers (PBS, phosphate, phosphste-citrate, ammunium acetate and bicarbonate), pH, amount of SnCl 2 and temperatures was studied for accepting maximum labeling yield. The high long-term radiochemical stability was accomplished through gluconate and bicarbonate buffer in pH range of 6-7. In addition to bicarbonate buffer, other buffers like as normal saline, phosphate, phosphate-citrate, PBS for accepting pH rang 6-7 was tested but radiochemical yield was unsuccessfull (less than 95% Tc were easily formed in high radiochemical yield (> 95%) even after 4 h. Tc using two tetra peptides chelators of CGGG and CSSS. The radiolabeled peptide showed reasonable shelf life and high radiochemical yield (> 95%) in solution.
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